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Active case findingBackground: Nigeria ranks 10th among 22 high TB burden countries with low TB case detec-
tion that relies on passive case finding. Although there is increasing body of evidence that
active case finding (ACF) has improved TB case finding in urban slums in some parts of the
world, this strategy had not been implemented in Nigeria despite the pervasiveness of
urban slums in the country.
Objective: To assess the yield and profile of TB in urban slums in Nigeria through ACF.
Methods: A prospective, implementation study was conducted in three urban slums of
southeastern Nigeria. Individuals with TB symptoms were identified through targeted
screening using a standardized questionnaire and investigated further for TB. Descriptive
and bivariate analyses were performed using SPSS.
Results: Among 16,743 individuals screened for TB, 6361 (38.0%) were identified as TB sus-
pects; 5894 suspects were evaluated for TB. TB was diagnosed in 1079 individuals, repre-
senting 6.4% of the screened population and 18.3% of those evaluated for TB. Of the 1079
cases found, 97.1% (n = 1084) had pulmonary TB (PTB), and majority (65%) had new
smear-positive TB. Children (<15 years) accounted for 6.7% of the cases. Also, 22.6% (216)
of the cases were HIV co-infected, among whom 55.1% (n = 119) were females. The average
number of individuals needed to screen to find a case of TB was 16.
Conclusions: There is high prevalence of TB in Nigeria slum population. Targeted screening
of out-patients, TB contacts, and HIV-infected patients should be optimized for active TB
case finding in Nigeria.
 2015 Asian African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.ahoo.com
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Introduction
Despite the progress made in the last decade, the urgency to
improve tuberculosis (TB) case findings remains one of the
leading concerns of national programs worldwide. The WHO
global TB control policy endorses the directly observed treat-
ment short course (DOTS) strategy which relies on symptom-
atic individuals voluntarily seeking care at health facilities as
the standard strategy for case findings [1]. While passive self-
presentation of patients advocated by the DOTS strategy was
shown to improve TB case detection in some high-TB burden
countries like Ethiopia, Peru and Vietnam [2,3], doubts of its
effectiveness, however, emerged with the rising human
immunodeficiency virus (HIV) epidemic [4]. In recent years,
the rate of TB case detection has stagnated, while the rate
of decline in estimated TB incidence has been slower than
expected [5,6]. Although, ‘‘passive case-finding’’ appears effi-
cient, as TB patients who voluntarily seek care at the health
facility are more likely to be symptomatic and their TB detect-
able through bacteriologic examination, a drawback of this
process is the decision of when and where to seek healthcare
and thus, contact with the health system, however, remains
with the patient. Patients seeking TB-related care through
passive self-presentation are likely to face barriers, such as
distance to the nearest health facility, gender, socioeconomic
factors, age, and lack of trained healthcare workers, which
have all been associated with patient and health system
delays from the onset of illness to treatment initiation [7–9].
Moreover, TB/HIV co-infection can result in atypical presenta-
tion of TB symptoms [10]; thus, HIV-infected individuals may
be less likely to suspect TB and be less likely to seek care for
TB. Active case finding (ACF) has been recommended as a
complementary approach to curtail delays in the care-seeking
pathway, especially in high TB/HIV settings [11]. Early diagno-
sis of bacteriologic-positive TB cases can potentially break the
chain of transmission ofMycobacterium tuberculosis to contacts
[12]. An extensive review found that ACF was effective in
reducing TB prevalence, incidence, and mortality from
disease complications [13]. The WHO recommends ACF strat-
egies to be conducted among targeted high-risk groups, such
as healthcare workers, HIV-positive individuals, miners,
urban slum dwellers, diabetic patients, smokers, prisoners,
immigrants and contacts of TB patients [11,12,14]. Studies
that explored ACF in detecting TB cases in a high-risk popula-
tion of urban slum dwellers who are poor, marginalized and
exposed to poor environmental conditions (overcrowding,
poor housing and poor living conditions) are crucial for TB
control programs in resource-poor settings [12–15].
With the WHO estimated TB incidence rate of 108 per
100,000 [5] and 3.4% HIV prevalence rate [16] in 2012, Nigeria
remains one of the countries with the highest TB and HIV bur-
den in the world. Almost a quarter (23%) of all TB cases noti-
fied in 2012 was HIV-infected [5], down from 26% the previous
year [17]. The 2012 national TB prevalence survey in the coun-
try showed that TB prevalence rates in adults aged 15 years
and above were estimated to be 318 per 100,000 population
for smear-positive, and 524 for bacteriologically-confirmed
cases [18]. Also, the survey showed that only one out of every
five active TB cases in the community was notified by theNigeria National TB Control Programme (NTP) – suggesting
detected and treated [18]. The NTP adopted the
WHO-approved DOTS strategy in 1993 and relies heavily on
passive case finding to identify TB cases. So far, little is known
about the feasibility of implementing active TB case finding
among urban slum populations which are inadequately
reached with TB services. This study, therefore, assessed the
yield, demographic and clinical characteristics of undetected
TB cases among urban slum populations in south-east
Nigeria.
Methods
Study design
A prospective, implementation study was carried out in three
urban slums in south-east Nigeria from 1 January to 31
December 2012.
Study setting
The study sites were three densely populated, low-income
urban slum settlements in Abia and Anambra States, south-
east Nigeria. Abia and Anambra States have an estimated
population of more than 8 million people. In Anambra State,
the study was implemented in two urban slums (Okpoko,
Aba and Mammy market) with an estimated population of
670,000. The population density in the slums were estimated
at 49.78 persons/hectare [19], and are inhabited by poor and
lower middle class families. Residential and sanitary condi-
tions are typical of any congested urban settlement. In Abia
State, the study was implemented in a slum area regarded
as the most densely populated slum in Nigeria, with a pro-
jected population of 471,516 [20]. The slum is comprised lar-
gely of a heterogeneous group of people, dump-sites and
displaced populations, the majority of who are living in
unstructured or informal temporary settlements. The slums
were selected through purposeful sampling after consultation
with the State Ministry of Health and local government area
(LGA) authorities.
Target population
The target population for the intervention was all individuals
utilizing the general outpatient department (GOPD) and HIV
clinics in health facilities in the study sites and contacts of
TB patients.
Selection of health facilities
The study was embedded in the existing health services in
the study area. There were 19 healthcare facilities within
the study area. These included 3 public and 16 private health
facilities. The 3 public health facilities were providing TB ser-
vices prior to the study and were selected for the study. Also,
an additional 9 private health facilities were selected through
purposeful sampling after consultation with the State
Ministry of Health, LGA authorities and heads of the facilities.
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vided both diagnostic and treatment services.
Intervention
Prior to the study, sensitization meetings were held with com-
munity leaders, chairs and ministries of local government,
directors of Primary Care, and relevant faith-based organiza-
tions in the study area and aimed at mobilizing community
resources and support for the study. TB messages were
disseminated through road shows, market shows and town
criers. TB messages were produced in posters, leaflets and
jingles, and focused on basic facts about TB and availability
of the services.
Three key sets of individuals were engaged to work on the
project. These included 120 community volunteers (consist-
ing of community members who indicated a willingness to
take part in the project), 32 general health workers (who
consisted of nurses, community health officers, community
health extension workers) and 12 laboratory personnel from
the study sites. To enhance the capacity of project staff to
effectively participate in the project, the community
volunteers (CVs) were given 1-week training on suspect
identification and referral, monitoring of TB treatment, and
recordkeeping, including completion of data collection tools.
The general health workers (GHWs) were offered a one-week
training course in TB and HIV services – suspect identifica-
tion, DOT administration and HIV counseling and testing
(HCT) – after which they were provided with data collection
tools. Also, a 1-week training course was held for the labora-
tory staff.
In the active case finding, screening of individuals for TB
symptoms was carried out by GHWs and CVs using simple,
standardized questionnaires. GHWs screened all individuals
who visited the general outpatient department (GOPD) and
HIV clinics in the selected health facilities for TB symptoms,
while trained CVs visited homes of TB patients to screen all
available household members for TB symptoms. TB symp-
toms assessed were cough, fever, weight loss, night sweats
and lymph node/spine/bone/abdominal swellings. Individu-
als with a coughP2 weeks with or without other clinical pre-
sentations were identified as pulmonary TB suspects. A
productive cough <2 weeks with the presence of one or more
TB-related symptoms was also considered as inclusion crite-
ria for pulmonary TB. In the case of an absence of cough, if an
individual had fever and the presence of one or more
TB-related symptoms, TB was suspected. Individuals
identified as TB suspects were referred to a TB clinic for fur-
ther evaluation by a clinician. If no symptoms were reported,
no further attempts were made.
For the diagnosis of TB among the suspects, those cough-
ing were requested to submit three sputum specimens (spot–
morning–spot) at the health facility for microscopy. Trained
laboratory staff guided patients on how to produce good qual-
ity sputum samples. Diagnosis of TB was made in line with
the NTP guidelines [21]. Pulmonary smear-positive was
defined as a positive sputum smear confirmed with one or
more positive smear. Pulmonary smear-negative was defined
by negative smear for AFB with radiology, clinical and/orhistology findings consistent with active TB, followed by the
decision made by a clinician to treat with a full course of TB
chemotherapy. Extra-pulmonary TB (EPTB) was based on his-
tological or strong clinical evidence consistent with active
EPTB, followed by the decision made by a clinician to treat
with a full course of TB chemotherapy. HIV counseling and
testing was provided to all persons with suspected TB during
submission of their sputum for microscopy.
TB treatment, support and care
All newly-diagnosed TB patients were started on first-line
anti-TB drugs in accordance with the NTP guidelines [21].
The GHWs and CVs followed up on patients who interrupted
treatment and encouraged them to commence or complete
TB treatment.
Data collection
Three trained local government TB supervisors visited the
health facilities weekly to supervise and retrieve collected
data. Data on all individuals screened for TB were obtained
from the screening forms/referral forms, while data on all
TB cases found were extracted from the TB treatment cards
and TB registers. This included: TB case registration, age,
sex, HIV status, smear status, type of TB.
Statistical analysis
Data were double-entered into a Microsoft access database by
two independent data operators were validated for inconsis-
tencies and were analyzed using the Statistical Package for
Social Sciences (SPSS) version 16.0. Patients’ demographic
and clinical characteristics were described in terms of fre-
quencies and percentages. Bivariate analyses were performed
with v2 test. A P-value <0.05 was considered statistically
significant.
Ethics approval
The Ethics Committee of the University of Nigeria Teaching
Hospital, Enugu, Nigeria approved the study. Permission was
also obtained from the National TB control program, Nigeria
and from the respective heads of the study facilities.
Results
Identification of symptomatic individuals and diagnosis
Over the one year period, 16,743 individuals were screened for
TB. Of these, 6361 (38.0%) were identified with symptoms sug-
gestive of active TB (Table 1), and 5894 (92.7% of the individu-
als identified with TB symptoms) were evaluated for TB. TB
was diagnosed in 1079 individuals representing 6.4% of the
screened population and 18.3% of those evaluated for TB.
About 65% (697/1079) were new smear-positive TB cases, with
conventional smear microscopy being the most common
form of diagnosis.
Overall, screening at the GOPD accounted for 90.5%
(15,159) of all individuals screened, while screening of
Table 2 – Demographic and clinical characteristics of TB
patients found (N = 1079).
Category n (%)
Gender
Female 447 (41.4)
Male 632 (58.6)
Age (years; n = 1079)
0–14 72 (6.7)
15–24 170 (15.8)
25–34 277 (25.7)
35–44 249 (23.1)
45–54 154 (14.3)
55–64 88 (8.2)
65+ 69 (6.4)
Type of TB
Pulmonary 1048 (97.1)
Extra-pulmonary 31 (2.9)
Case registration
New cases 944 (87.5)
Retreatment cases 135 (12.5)
Extra-pulmonary sites (n = 31)
Spondylitis 19 (61.3)
Lymphadenitis 3 (9.7)
Abdominal 1 (3.2)
Bone and joint 3 (9.7)
Unknown 5 (16.1)
HIV status
Positive 216 (20.0)
Negative 739 (68.5%)
Unknown 124 (11.5%)
HIV care (n = 216)
Received CPT 133 (61.6)
Received ART 146 (67.6)
TB = tuberculosis; CPT = Cotrimoxazole Preventive Therapy;
ART = Anti-Retroviral Therapy.
Table 1 – Characteristics of patients identified through screening and testing.
Variable Total (n) Contact tracing (n) GOPD (n) HIV clinic (n)
Individuals screened 16,743 192 15,159 1392
Individuals identified with symptoms of TB 6361 98 5298 965
Individuals of tested 5894 64 5298 532
TB cases (all forms) 1079 10 923 146
TB cases (new smear positive) 697 5 615 77
NNS (number needed to screen) 16 19 16 10
TB cases (all form) as % of screened 6.4 5.2 6.1 10.5
TB cases (all forms) as % of tested 18.3 15.6 17.4 27.4
TB = tuberculosis; GOPD = general outpatients department.
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accounted for 1.2% (192) and 8.3% (1392) of individuals
screened, respectively. More than a quarter (146; 27%) of
HIV-infected individuals (532) tested for TB had TB. The num-
ber of individuals needed to screen (NNS) to find one case of
TB in the study was 16. However, when disaggregated by
intervention, the NNS to find one case of TB was 19 among
contacts of TB patients, 16 in GOPD and 10 among HIV-
infected persons (Table 1).Characteristics of TB patients detected
Among the individuals diagnosed with TB (1079), 447 (41.4%)
were females, 72 were children (<15 years) (6.7%), 944 (87.5)
were new cases, and 12.5% (135) were previously treated TB
cases (Table 2). The majority (97.1%; 1,048) of them had pul-
monary TB (PTB), while about 2.9% (31) had EPTB, with spon-
dylitis accounting for more than half (61.3%) of these cases.
Only 955 (88.5% of the individuals diagnosed with TB) were
tested for HIV co-infection, while the remaining 124 (11.5)
declined HIV testing. Of those tested for HIV, the rate of
TB/HIV co-infection was 22.6% (216), the majority (55.1%;
119) of whom were females. The rate of cases of TB was
highest among individuals aged 25–44 years, while children
(0–14 years) and the elderly (65+ years) had the lowest propor-
tions of cases of TB (Table 2).
Of the 944 new cases found, 697 (73.8%) had smear-positive
PTB, 216 (22.9%) had smear-negative PTB and 31 (3.3%) had
EPTB. Also, TB/HIV co-infection rate among new cases tested
for HIV (850) was 22.8% (194). Furthermore, of the 135 re-treat-
ment cases, 77 (57.0%) had smear-positive PTB, and 58 (43.0%)
had smear-negative PTB. TB/HIV co-infection rate among re-
treatment cases tested for HIV (105) was 21.0% (22). The
male–female ratio among all and new cases found was 1.4:1
and 1.3:1, respectively (Table 3).
Upon further evaluation, the distribution of TB cases was
found to be in accordance with registration status (Table 3)
and gender (Table 4). In new versus re-treatment cases
(Table 3), new cases found were significantly younger (7.6%
vs. 0; p < 0.001), had higher EPTB cases (3.3% vs. 0; p = 0.04),
but with less TB/HIV patients on ART (63.9% vs. 100%;
p = 0.001). Furthermore, compared with male cases found
(Table 4), females were significantly younger (<15 years)
(9.4% vs. 4.7%; p = 0.004), had a higher rate of HIV co-infection
(28.1% vs. 18.3%; p < 0.001) and a higher proportion of TB/HIV
patients on ART (79.4% vs. 57%; p < 0.001).
Discussion
In this study, it was found that 6.4% of the targeted population
in three slum settings screened had TB, with 65% of cases
being new smear-positive TB. The average overall number of
people needed to screen to find one case of TB was 16–being
19 among TB contacts, 16 in GOPD attendees and 10 in HIV
patients. Most of the cases found were males, and about
one-fourth of them were co-infected with HIV. Almost half
Table 3 – Relationships between demographic and clinical variables and type of TB (N = 1079).
Variables Total
n (%)
New cases
n (%)
Retreatment cases
n (%)
Chi-square P-value
Age (years)
<15 72 (6.7) 72 (7.6) 0 (0.0) 8.95 <0.001
P15 1007 (93.3) 872 (92.4) 135 (100.0)
Gender
Female 447 (41.4) 399 (42.3) 52 (38.5) 0.68 0.47
Male 632 (58.6) 545 (57.7) 83 (61.5)
Type of TB
PTB 1048 (97.1) 913 (96.7) 135 (100.0) 2.68 0.042
EPTB 31 (2.9) 31 (3.3) 0 (0.0)
HIV positive (n = 955)
Yes 216 (22.6) 194 (22.8) 22 (21.0) 0.19 0.77
No 739 (77.4) 656 (77.2) 83 (79.0)
CPT use (n = 216)
Yes 133 (61.6) 122 (62.9) 11 (50.0) 1.38 0.34
No 83 (38.4) 72 (37.1) 11 (50.0)
ART use (n = 216)
Yes 146 (67.6) 124 (63.9) 22 (100.0) 9.36 0.001
No 70 (32.4) 70 (36.1) 0 (0.0)
TB = tuberculosis; EPTB = Extra-pulmonary; CPT = Cotrimoxazole Preventive Therapy; ART = Anti-Retroviral Therapy.
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elderly had the lowest proportions of cases. Females were sig-
nificantly younger, had higher rates of HIV co-infection and
were more likely to be on ART.
These findings reveal a high prevalence of TB, mostly
smear-positive TB. This suggests that there is a likelihood of
a high community transmission of TB in the population stud-
ied. The underlying factors promoting this transmission are
likely due to overcrowding, poor housing and poor livingTable 4 – Relationships between demographic and clinical varia
Variables Total
n (%)
Male
n (%)
Age (years)
<15 72 (6.7) 30 (4.7)
P15 1007 (93.3) 602 (95.3)
Type of TB
PTB 1048 (97.1) 616 (97.5)
EPTB 31 (2.9) 16 (2.5)
Case registration
New 944 (87.5) 545 (86.8)
Re-treatment 135 (12.5) 83 (13.2)
HIV positive (n = 955)
Yes 216 (22.6) 97 (18.3)
No 739 (77.4) 434 (81.7)
CPT use (216)
Yes 133 (61.6) 68 (57.1)
No 83 (38.4) 51 (42.9)
ART use (216)
Yes 146 (67.6) 65 (57.0)
No 70 (32.4) 49 (43.0)
TB = tuberculosis; EPTB = Extra-pulmonary; PTB = Pulmonary TB; CPT = Cconditions [12–15]. Overall, the yield of TB in this study was
higher than in similar studies conducted elsewhere, i.e.,
3.5% in Uganda [12], 0.2% in Cambodia [22] and 0.3% in Ban-
gladesh [14]. The high yield of TB observed is an indicator of
high underlying TB and HIV prevalence in urban slum
settings of Nigeria and agrees with the findings of the recent
TB prevalence survey in the country which showed that the
majority of TB cases (most being smear-positive) in the
community are not notified to the NTP [5].bles and gender of cases (N = 1079).
Female
n (%)
Chi-square P-value
42 (9.4) 9.08 0.004
405 (90.6)
432 (96.6) 0.73 0.54
15 (3.4)
399 (88.5) 0.68 0.47
52 (11.5)
119 (28.1) 12.92 <0.001
305 (71.9)
65 (67.0) 2.19 0.18
32 (33.0)
81 (79.4) 12.27 <0.001
21 (20.6)
otrimoxazole Preventive Therapy; ART = Anti-Retroviral Therapy.
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outcomes of the systematic screening of high risk groups
for TB. Although targeted screening of GOPD attendees
accounted for substantial yields of TB cases, the intervention
that appeared to be most effective based on the NNS was
screening of people living with HIV/AIDS (PLWHIV), while
the least effective was the screening of contacts of TB
patients. This finding was consistent with findings from
Rwanda, Ethiopia, Brazil and Peru where continuous screen-
ing of PLWHIV at HIV clinics was consistently found to have
substantial yields from TB screening projects [11,14,23]. This
study also showed that more than a quarter of the HIV-
infected individuals tested for TB had TB, reinforcing the need
to prioritize and promote early case finding strategies among
PLWHIV. The NTP currently promotes TB/HIV collaborative
activities [21]. There is a need to strengthen these mecha-
nisms for collaboration and orient it toward active detection
of TB in PLWHIV. And, as documented elsewhere [11,23],
active TB case finding in GOPD attendees should be consid-
ered among innovative approaches to promote early TB
detection in Nigeria.
The age-specific distribution of TB showed that TB was
most common in the 25–44 year age group in this study. This
finding is consistent with findings in Nigeria, Kenya and India
[24–26]. In contrast, in Cambodia, China and Vietnam, the age
group most affected was 65 years and older, followed by the
45–54 year age group [27]. The reasons for these differences
are not clear; it may be due to differing levels of economic
and demographic transition and TB transmission occurring
in these countries. The male–female ratio was 1.4:1 among
all TB cases found – a consistent observation in several other
countries [28]. The age-gender distribution indicates that TB
was more among the younger females than males, but
reverses at an older age. The difference in the gender distribu-
tion of TB observed may be due to the epidemiologic situation
in the setting concerned. However, biological mechanisms
and cultural factors leading to differences in access to health
services have been implicated as possible reasons for differ-
ences in TB susceptibility between men and women [29].
The strength of this study was that it explored varying
active case finding and systematic screening strategies in a
poor and marginalized setting believed to have a high burden
of TB, and it improved the capacity of the health facilities
across the slums, including the private sector, for TB care.
Also, data were collected and verified monthly for errors
and consistency. However, the study also had some
limitations. First, the urban slumswere purposefully selected.
This was because the areas are inadequately reached with TB
services in spite of their greater need for such services. Sec-
ond, data on CD4 cell count were not collected for HIV-posi-
tive individuals. Differences in CD4 cell count may be
responsible for the high undetected TB in PLWHIV; previous
studies have demonstrated an association between TB occur-
rence and a decrease in CD4 cell counts in PLWHIV [30]. More-
over, the higher incidence of TB in women infected with HIV
despite a higher proportion being on ART suggests a poor
quality of HIV care or delays in initiating ART; this warrants
further studies. Finally, it is not known how many of the
individuals with TB cases notified through the intervention
would have sought care at a DOTS facility in the absence ofthe intervention, nor is it known if the intervention reduced
barriers faced by special groups like women in accessing TB
services; these issues should be considered and evaluated fur-
ther in future active TB case finding interventions.
Conclusion
It was found that 6.4% of the individuals screened had TB,
with a majority being smear-positive. Therefore, ACF is feasi-
ble and can contribute to improved TB case detection in urban
slums in resource-limited settings like Nigeria. It is recom-
mended that: (1) targeted screening of GOPD attendees, TB
contacts, and PLWHIV should be considered in active case
finding strategies in the setting; (2) TB/HIV collaborative activ-
ities need to be strengthened and proximate determinants of
TB in HIV-infected individuals need to be identified to opti-
mize TB case detection in PLWHIV; (3) Future ACF strategies
should evaluate its impact in reducing barriers of access to
TB services in women; and (4) Other ACF strategies, e.g., com-
munity outreach and in-patients with diabetes mellitus,
should be considered in future studies.
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